Target
Tyrosine-protein kinase JAK2 [808-1132]
Ligand
BDBM103736
Substrate
n/a
Meas. Tech.
JAK2 Inhibition Assay
IC50
65.4±n/a nM
Citation
 Menet, CJSmits, KK Compound useful for the treatment of degenerative and inflammatory diseases US Patent  US11000528 Publication Date 5/11/2021 
Target
Name:
Tyrosine-protein kinase JAK2 [808-1132]
Synonyms:
JAK2 | JAK2_HUMAN | Janus kinase 2 (JAK2) | Tyrosine-protein kinase JAK2 | Tyrosine-protein kinase JAK2 (808-1132)
Type:
n/a
Mol. Mass.:
37984.02
Organism:
Homo sapiens (Human)
Description:
808-1132 aa of O60674
Residue:
325
Sequence:
LFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM103736
Synonyms:
US10206907, Compound 207 | US11000528, Cpd # 10 | US8563545, 10
Type:
Small organic molecule
Emp. Form.:
C21H21N5O4S
Mol. Mass.:
439.488
SMILES:
O=C(Nc1nc2cccc(-c3ccc(cc3)C(=O)N3CCS(=O)(=O)CC3)n2n1)C1CC1
Structure:
Search PDB for entries with ligand similarity: